🇺🇸
United States · US · US:0713-0897_437e6c45-dfb9-35ec-e063-6394a90a7874
Vyleesi
Orange BookUNIISPLATC G02CX05
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerCosette Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeG02CX05
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1107130897044 SYRINGE in 1 CARTON (0713-0897-04) / .3 mL in 1 SYRINGE (0713-0897-06)
Annotations
UNII (FDA Substance ID)
PV2WI7495P
BREMELANOTIDE ACETATE
RxCUI 2176311
Orange Book
N210557
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "PV2WI7495P",
"rxcui": "2176311",
"inchikey": "MAYUSRUHXFWITM-GBRHMYBBSA-N",
"display_name": "BREMELANOTIDE ACETATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf": {
"match": "brand_token",
"title": "VYLEESI (BREMELANOTIDE) INJECTION [COSETTE PHARMACEUTICALS, INC.]",
"spl_version": "1",
"published_date": "2025-11-18"
}
},
"productid": "0713-0897_437e6c45-dfb9-35ec-e063-6394a90a7874",
"productndc": "0713-0897",
"dosage_form": "INJECTION",
"orange_book": {
"appl_no": "210557",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML)",
"product_no": "001",
"approval_date": "Jun 21, 2019"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "BREMELANOTIDE ACETATE",
"proprietary_name": "Vyleesi",
"active_ingred_unit": "mg/.3mL",
"application_number": "NDA210557",
"marketing_category": "NDA",
"nonproprietary_name": "bremelanotide",
"start_marketing_date": "20251112",
"active_numerator_strength": "1.75"
}Related drugs
Other records sharing ATC code G02CX05.
Access this data programmatically
Query Vyleesi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.